Sales rose 13.5% to RON201.24 million, from RON177.32 million, according to financial results published on the Bucharest Stock Exchange.
In the timeframe analyzed, exports reached a value of $12.75 million.
Nine-month revenue rose 11.3% on the year, to RON216.88 million, while expenditure increased by 11.1%, to RON187.64 million.
At the end of September, the company had a short-term debt of RON124.44 million, up 12% since the beginning of the year. On the other hand, receivables rose 20% to RON216.18 million
The company is 53.02% owned by the Health Ministry, while SIF Oltenia (SIF5.RO) holds a 10.09% stake.
Antibiotice shares closed up 0.47% Monday, to RON0.43. (EUR1=RON4.3448)